| PROCEPT BioRobotics Corp |
Director |
Common Stock |
14,363 |
$839,660 |
$58.46 |
14 Aug 2025 |
By The 2:22 DNA Trust |
| PROCEPT BioRobotics Corp |
Director |
Common Stock |
35,152 |
$46,752 |
$1.33 |
14 Aug 2025 |
Direct |
| PROCEPT BioRobotics Corp |
Director |
Stock Option (Right to Buy) |
0 |
$11,519 |
$4.56 |
14 Aug 2025 |
Direct |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Barred Owl Partners, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By CD Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By CPMG, Inc. |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Crested Crane, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Elepaio Partners, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Gallopavo, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Kestrel Fund, LP( |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Killdeer Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Mallard Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Managed Account for Trustees of the University of Pennsylvania |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Nighthawk Partners, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Redbird Life Sciences Partners, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Roadrunner Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Sandpiper Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By The 2:22 DNA Trust |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Willet Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Yellow Warbler, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By CD Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By CPMG, Inc. |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Kestrel Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Mallard Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Redbird Life Sciences Partners, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Willet Fund, LP |
| REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
26 Sep 2023 |
By Yellow Warbler, LP |